We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacokinetics studies of enrofloxacin injectable in situ forming gel in dogs.
- Authors
Li, H.‐M.; Tian, J.; Zhang, Z.‐R.; Luo, X.‐Q.; Yu, Z.‐G.
- Abstract
The objective of this study was to evaluate the pharmacokinetic characteristics of enrofloxacin (ENR) injectable in situ gel we developed in dogs following a single intramuscular (i.m.) administration. Twelve healthy dogs were randomly divided into two groups (six dogs per group), then administrated a single 20 mg/kg body weight (b.w.) ENR injectable in situ gel and a single 5 mg/kg b.w. ENR conventional injection, respectively. High-performance liquid chromatography (HPLC) was used to determine ENR plasma concentrations. The pharmacokinetic parameters of ENR injectable in situ gel and conventional injection in dogs are as follows: MRT (mean residence time) (45.59 ± 14.05) h verse (11.40 ± 1.64) h, AUC (area under the blood concentration vs. time curve) (28.66 ± 15.41) μg·h/mL verse (11.06 ± 3.90) μg·h/mL, cmax (maximal concentration) (1.59 ± 0.35) μg/mL verse (1.46 ± 0.07) μg/mL, tmax (time needed to reach cmax) (1.25 ± 1.37) h verse (1.40 ± 0.55) h, t1/2λz (terminal elimination half-life) (40.27 ± 17.79) h verse (10.32 ± 0.97) h. The results demonstrated that the in situ forming gel system could increase dosing interval of ENR and thus reduced dosing frequency during long-term treatment. Therefore, the ENR injectable in situ gel seems to be worth popularizing in veterinary clinical application.
- Subjects
PHARMACOKINETICS; DRUG metabolism; ANIMAL health; DOGS; METABOLITES; METABOLIC clearance rate
- Publication
Journal of Veterinary Pharmacology & Therapeutics, 2016, Vol 39, Issue 2, p144
- ISSN
0140-7783
- Publication type
Article
- DOI
10.1111/jvp.12255